Data monitoring, auditing, and interim analysis
Data monitoring and auditing will be conducted by the funding agency annually. An interim analysis will be performed by an independent statistician when half of the patients have been randomized. The trial will be stopped if one treatment is found to be statistically more beneficial or harmful than the other.